Cytokine regulation of Group II phospholipase A2 expression in glomerular mesangial cells

  • J. Pfeilschifter
  • H. Mühl
  • W. Pignat
  • F. Märki
  • H. van den Bosch
Article

Summary

Phospholipase A2 (PLA2) is believed to play an essential role in inflammatory processes by releasing arachidonic acid from membrane phospholipids for synthesis of important lipid mediators, such as prostaglandins, leukotrienes and platelet activating factor.

We have used glomerular mesangial cells as a model system to study the regulation of PLA2 under inflammatory conditions. Potent pro-inflammatory cytokines, such as interleukin 1 (IL-1) and tumour necrosis factor α (TNFα), as well as agents that increase cellular cAMP levels have been found to increase Group II PLA2 gene expression in a time- and dose-dependent manner.

In all cases cytokine-induced synthesis of PLA2 occurred in parallel with cytokine-stimulated prostaglandin (PG) E2 synthesis. Three important classes of compounds that potently antagonise the stimulatory effect of IL-1, TNFα and cAMP on Group II PLA2 expression in mesangial cells have been identified, namely, glucocorticoids, transforming growth factors (TGF) type-β and platelet-derived growth factor (PDGF). Those agents may act sequentially to protect the kidney from damage resulting from cytokine-stimulated mediator release and the subsequent inflammatory reactions.

Key words

Phospholipase A2 Mesangial cell Cytokines interleukin 1 tumour necrosis factor α transforming growth factorβ platelet-derived growth factor glucocorticoids 

References

  1. 1.
    Van den Bosch H (1980) Intracellular phospholipases A. Biochim Biophys Acta 604:191–246PubMedGoogle Scholar
  2. 2.
    Pruzanski W, Vadas P (1991) Phospholipase A2 — a mediator between proximal and distal effectors of inflammation. Immunol Today 12:143–146PubMedGoogle Scholar
  3. 3.
    Wijkander J, Sundler R (1989) A phospholipase A2 hydrolyzing arachidonoyl-phospholipids in mouse peritoneal macrophages. FEBS Lett 244:51–56PubMedGoogle Scholar
  4. 4.
    Clark JD, Milona N, Knopf JL (1990) Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937. Proc Natl Acad Sci USA 87:7708–7712PubMedGoogle Scholar
  5. 5.
    Gronich JH, Bonventre JV, Nemenoff RA (1990) Purification of a high-molecular-mass form of phospholipase A2 from rat kidney activated at physiological calcium concentrations. Biochem J 271:37–43PubMedGoogle Scholar
  6. 6.
    Pfeilschifter J, Pignat W, Vosbeck K, Märki F (1989) Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells. Biochem Biophys Res Commun 159:385–394PubMedGoogle Scholar
  7. 7.
    Märki F, Franson R (1986) Endogenous suppression of neutralactive and calcium-dependent phospholipase A2 in human polymorphonuclear leukocytes. Biochim Biophys Acta 879:149–156PubMedGoogle Scholar
  8. 8.
    Mühl H, Geiger T, Pignat W, Märki F, Van den Bosch H, Vosbeck K, Pfeilschifter J (1991) PDGF suppresses the activation of group 11 phospholipase A2 gene expression by interleukin 1 and forskolin in mesangial cells. FEBS Lett 291:249–252PubMedGoogle Scholar
  9. 9.
    Pfeilschifter J, Mühl H (1990) Interleukin 1 and tumor necrosis factor potentiate angiotensin II- and calcium ionophore-stimulated prostaglandin E2 synthesis in rat renal mesangial cells. Biochem Biophys Res Commun 169:585–595PubMedGoogle Scholar
  10. 10.
    Schalkwijk C, Pfeilschifter J, Märki F, Van den Bosch H (1991) Interleukin-lβ, tumor necrosis factor and forskolin stimulate the synthesis and secretion of group II phospholipase A2 in rat mesangial cells. Biochem Biophys Res Commun 174:268–275PubMedGoogle Scholar
  11. 11.
    Pfeilschifter J, Leighton J, Pignat W, Märki F, Vosbeck K (1991) Cyclic AMP mimics, but does not mediate, interleukin-l- and tumour-necrosis-factor-stimulated phospholipase A2 secretion from rat renal mesangial cells. Biochem J 273:199–204PubMedGoogle Scholar
  12. 12.
    Mühl H, Geiger T, Pignat W, Märki F, Van den Bosch H, Cerletti N, Cox D, McMaster G, Vosbeck K, Pfeilschifter J (1992) Transforming growth factors type-β and dexamethasone attenuate group II phospholipase A2 gene expression by interleukin-1 and forskolin in rat mesangial cells. FEBS Lett 301:190–194PubMedGoogle Scholar
  13. 13.
    Schalkwijk C, Vervoordeldonk M, Pfeilschifter J, Märki F, Van den Bosch H (1991) Cytokine- and forskolin-induced synthesis of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by dexamethasone. Biochem Biophys Res Commun 180:46–52PubMedGoogle Scholar
  14. 14.
    Pfeilschifter J, Pignat W, Leighton J, Märki F, Vosbeck K, Alkan S (1990) Transforming growth factorβ 2 differentially modulates interleukin-1β- and tumour-necrosis-factor-α-stimulated phospholipase A2 and prostaglandin E2 synthesis in rat renal mesangial cells. Biochem J 270:269–271PubMedGoogle Scholar
  15. 15.
    Schalkwijk C, Pfeilschifter J, Märki F, Van den Bosch H (1992) Interleukin-1β- and forskolin-induced synthesis and secretion of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by transforming growth factor-β2. J Biol Chem 267:8846–8851PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • J. Pfeilschifter
    • 1
  • H. Mühl
    • 1
  • W. Pignat
    • 2
  • F. Märki
    • 2
  • H. van den Bosch
    • 3
  1. 1.Department of Pharmacology, BiocenterUniversity of BasleBaselSwitzerland
  2. 2.Pharmaceuticals DivisionResearch DepartmentGiba-Geigy, BasleSwitzerland
  3. 3.Centre for Biomembranes and Lipid EnzymologyUtrechtThe Netherlands

Personalised recommendations